APA (7th ed.) Citation

Kang, M., Shin, J. I., Han, S., Kim, J. Y., Park, J., Kim, K. I., . . . Lee, T. S. (2022). Therapeutic Response Monitoring with ⁸⁹Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models. MDPI AG.

Chicago Style (17th ed.) Citation

Kang, Minwoo, Jong Il Shin, Sangjin Han, Jung Young Kim, Jeonghoon Park, Kwang Il Kim, Joo Hyun Kang, and Tae Sup Lee. Therapeutic Response Monitoring with ⁸⁹Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models. MDPI AG, 2022.

MLA (9th ed.) Citation

Kang, Minwoo, et al. Therapeutic Response Monitoring with ⁸⁹Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models. MDPI AG, 2022.